Teleflex Incorporated (NYSE:TFX) Shares Acquired by JPMorgan Chase & Co.

JPMorgan Chase & Co. raised its stake in Teleflex Incorporated (NYSE:TFX) by 14.3% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 155,158 shares of the medical technology company’s stock after buying an additional 19,466 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.33% of Teleflex worth $38,374,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of TFX. Oregon Public Employees Retirement Fund boosted its holdings in shares of Teleflex by 1.2% in the second quarter. Oregon Public Employees Retirement Fund now owns 4,021 shares of the medical technology company’s stock valued at $846,000 after acquiring an additional 46 shares in the last quarter. Cromwell Holdings LLC boosted its position in shares of Teleflex by 59.0% in the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after buying an additional 49 shares during the period. Apollon Wealth Management LLC increased its stake in Teleflex by 3.7% in the 3rd quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock valued at $377,000 after buying an additional 55 shares during the period. SRS Capital Advisors Inc. raised its holdings in shares of Teleflex by 0.3% during the third quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock worth $4,844,000 after acquiring an additional 60 shares in the last quarter. Finally, Janney Montgomery Scott LLC increased its stake in shares of Teleflex by 0.4% during the 3rd quarter. Janney Montgomery Scott LLC now owns 15,332 shares of the medical technology company’s stock worth $3,792,000 after purchasing an additional 65 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Stock Up 1.5 %

NYSE:TFX opened at $181.75 on Monday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The stock has a market cap of $8.44 billion, a price-to-earnings ratio of 36.13, a PEG ratio of 1.84 and a beta of 1.16. The stock has a 50-day moving average price of $190.92 and a two-hundred day moving average price of $217.28. Teleflex Incorporated has a 1 year low of $171.69 and a 1 year high of $256.85.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, topping the consensus estimate of $3.38 by $0.11. The company had revenue of $764.40 million during the quarter, compared to analysts’ expectations of $768.68 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Teleflex’s revenue for the quarter was up 2.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.64 earnings per share. As a group, equities analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, December 16th. Shareholders of record on Friday, November 15th were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date was Friday, November 15th. Teleflex’s dividend payout ratio (DPR) is presently 27.04%.

Wall Street Analysts Forecast Growth

TFX has been the subject of several analyst reports. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Mizuho dropped their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Truist Financial decreased their price objective on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th. Finally, Royal Bank of Canada decreased their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, Teleflex presently has an average rating of “Moderate Buy” and an average price target of $252.50.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.